Technical Programme

February 3, 2017 (Friday)

Session II : Cancer Therapeutics

09:15 hrs   



  • Kapil Dhingra, MD; Retired Vice President, Roche, Director, KAPital Consulting LLC
  • Phil Dawson, Ph.D., Associate Dean of Graduate Studies, Department of Chemistry California, Campus, The Scripps Research Institute

09.30 hrs

Kapil Dhingra

“Enabling personalized medicine in oncology: Current status and perspectives on the future”

Kapil Dhingra, MD
Retired Vice President, Roche,
Director, KAPital Consulting LLC

10:00 hrs Martin Pule

“T-cell engineering for Cancer Application”

Martin Pule, M.D.
Founder & Chief Scientific Officer
Autolus Limited

10:30 hrs

“ZYTP1 -  a novel PARP inhibitor for management of solid tumors”

Mukul Jain, Ph. D.
Senior V P, Pharmacology & Toxicology
Zydus Research Center

11:00 hrs


11:30 hrs

Lewis T. Williams

“Discovery of New Protein Drug Targets by Comprehensively Screening the Extracellular Proteome”

Lewis T. "Rusty" Williams, M.D., Ph.D.
Founder, President and CEO,
Five Prime Therapeutics, Inc.

12:00 hrs

Karen Reue

“Mouse Models for Pharmacogenomic Discovery”

Karen Reue, Ph.D.
Professor, Human Genetics, Department of Human
Genetics, David Geffen School of Medicine,
University of California, Los Angeles

12:30 hrs

Lunch & Poster Sessions

Session III : Anti-infectives & Public Health


  • Bikash Medhi, MBBS,MD(AIIMS),MAMS,FIMSA Professor, Department of Pharmacology, PGIMER, Chandigarh
  • Reinhard Glueck, Ph.D; Chief Scientific Officer Zydus-VTC

14:00 hrs

“Public-Private Partnerships to Accelerate Innovation in Product Development”

Rajeev Venkayya, MD
President of Global Vaccine Business Unit,
Takeda Pharmaceuticals

14:30 hrs

Jorg Mohrle

“Developing next-generation malaria medicines to address drug resistance and increase the operational feasibility of malaria elimination efforts”

Jörg Möhrle, Ph.D.
Vice President, Head of Translational Medicine, Research & Development, Medicines for Malaria Venture

15:00 hrs


15:30 hrs

“The Discovery and Development of New Antivirals”

Manoj Desai, Ph.D.
Vice President, Medicinal Chemistry
Gilead Sciences

16:00 hrs

“Opportunities and Challenges in the Vaccine Industry"

Rahul Singhvi, Sc.D.
Chief Operating Officer,
Takeda Vaccines

16:30 hrs

Panel Discussion
“Is there more integration between cancer, viral disease and the microbiome?”

  • Jeff Flier, M.D., HMS Dean (2007-16), Harvard Medical School,
  • Richard DiMarchi, Ph.D., Standiford H. Cox Distinguished Professor of Chemistry, Linda & Jack Gill Chair in Biomolecular Sciences, Indiana University
  • Rajeev Venkayya, MD, President of Global Vaccine Business Unit, Takeda Pharmaceuticals
  • Kapil Dhingra, MD, Retired Vice President, Roche, Director, KAPital Consulting LLC
  • Manoj Desai, Ph.D., Vice President, Medicinal Chemistry, Gilead Sciences
  • Arun Sanyal, MD, Professor of Medicine, Physiology and Molecular Pathology, Virginia Commonwealth University

17:30 hrs


Venue :

Gujarat University Convention and Exhibition Centre
132 Ring Road,
Near Helmet Circle,
Opp Mayflower Hospital,
Ahmedabad, Gujarat- 380009.


Home Contact Us Life-sciences Exhibition